Lallemand Michael S, Moe Donald M, McClellan John M, Smith Joshua P, Daab Leo, Marko Shannon, Tran Nam, Starnes Benjamin, Martin Matthew J
Department of Surgery (M.S.L., D.M.M., J.M.M., J.P.S., L.D., S.M., M.J.M.), Madigan Army Medical Center, Fort Lewis, Washington; Department of Vascular Surgery (N.T., B.S.), University of Washington, Seattle, WA; and Trauma and Emergency Surgery Service (M.J.M.), Legacy Emanuel Medical Center, Portland, Oregon.
J Trauma Acute Care Surg. 2017 Aug;83(2):230-236. doi: 10.1097/TA.0000000000001548.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a rescue maneuver for unstable patients with noncompressible hemorrhage below the diaphragm. The efficacy of REBOA in the setting a major abdominal venous injury is unknown. Our objective was to examine the use of REBOA in a large animal model of major abdominal venous injury and characterize any impact on the hemodynamics, rate and volume of hemorrhage, and survival.
Ten swine (35-55 kg) underwent a controlled and validated hemorrhage and ischemia/reperfusion injury protocol to produce shock physiology. Animals were randomly assigned to a control arm (N = 5) or a treatment (REBOA) arm (N = 5). An injury was then created in the common iliac vein. Bleeding was allowed for 60 seconds and the balloon was then inflated in the REBOA arm. Hemodynamics were recorded for 45 minutes or until death. Blood loss was verified post-mortem and bleeding rate calculated.
All animals demonstrated shock physiology at the time of randomization. There were no differences between control versus REBOA animals in baseline mean arterial pressure (42 vs. 50), pH (7.29 vs. 7.26), lactate (6.19 vs. 6.26), or INR (1.2 vs. 1.3, all p = NS). REBOA animals demonstrated immediate improvements in mean arterial pressure (50.6 vs. 97.2, p = 0.04). The mean survival time was 4.1 minutes for controls (100% died) versus 40.1 minutes for REBOA (p < 0.01). There was no difference in total blood loss (mean 630 mL for both). The rate of bleeding was significantly lower in the REBOA animals (control 197 mL/min vs. REBOA 14 mL/min, p = 0.02).
In the setting of an abdominal venous injury, REBOA improved hemodynamics and lengthened survival time. Blood loss was similar between groups but the rate of bleeding was markedly decreased with REBOA. REBOA appears effective for central venous injuries and provides a sustained period of stabilization and window for surgical intervention.
主动脉内复苏球囊阻断术(REBOA)是用于治疗膈肌以下不可压迫性出血的不稳定患者的一种抢救措施。REBOA在严重腹部静脉损伤情况下的疗效尚不清楚。我们的目的是研究REBOA在大型动物严重腹部静脉损伤模型中的应用,并确定其对血流动力学、出血速率和出血量以及生存率的影响。
十头猪(35 - 55千克)接受了一项经过控制和验证的出血及缺血/再灌注损伤方案,以产生休克生理状态。动物被随机分为对照组(N = 5)或治疗(REBOA)组(N = 5)。然后在髂总静脉制造损伤。出血60秒后,在REBOA组中充盈球囊。记录血流动力学45分钟或直至死亡。死后核实失血量并计算出血速率。
所有动物在随机分组时均表现出休克生理状态。对照组与REBOA组动物在基线平均动脉压(42对50)、pH值(7.29对7.26)、乳酸(6.19对6.26)或国际标准化比值(1.2对1.3,所有p值均无统计学意义)方面无差异。REBOA组动物的平均动脉压立即得到改善(50.6对97.2,p = 0.04)。对照组的平均生存时间为4.1分钟(100%死亡),而REBOA组为40.1分钟(p < 0.01)。总失血量无差异(两组均平均为630毫升)。REBOA组动物的出血速率显著更低(对照组197毫升/分钟对REBOA组14毫升/分钟,p = 0.02)。
在腹部静脉损伤的情况下,REBOA改善了血流动力学并延长了生存时间。两组间失血量相似,但REBOA显著降低了出血速率。REBOA似乎对中心静脉损伤有效,并为手术干预提供了一段持续的稳定期和窗口期。